About
Clinical Research
Areas of Focus
Categories
Clinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchCg RegulatoryClinical ResearchNJ, NY, PA
Clinical Trials (19)
View allTotal Trials
19
As Lead Sponsor
13
As Collaborator
6
Total Enrollment
850
By Phase
PHASE2: 9PHASE1/PHASE2: 6PHASE1: 2NA: 1
By Status
COMPLETED: 6TERMINATED: 4RECRUITING: 3ACTIVE_NOT_RECRUITING: 2UNKNOWN: 2NOT_YET_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline19 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06992258Lead Sponsor
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
PHASE2Not yet recruiting
120 participants
Started: Sep 15, 2025 · Completed: Dec 31, 2028
NCT05458674Lead Sponsor
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
PHASE2Recruiting
30 participants
Started: Jan 30, 2024 · Completed: Aug 1, 2027
NCT05230810Lead Sponsor
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
PHASE1/PHASE2Recruiting
40 participants
Started: Aug 25, 2022 · Completed: Jun 30, 2025
NCT05167409Collaborator
A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
PHASE2Active, not recruiting
48 participants
Started: Jul 28, 2022 · Completed: Mar 1, 2026
NCT05180422Lead Sponsor
A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis
PHASE1/PHASE2Withdrawn
Started: Jun 15, 2022 · Completed: Jan 31, 2023
Funding History (1)
D
Jun 11, 2014
Locations (1)
Headquarters
Saratoga Springs, NY, United States
Map
Loading map...